IP Library Granted Patent US 10,159,812
Granted Patent B2
US 10,159,812 · App. 13/074,990 · Granted Dec 25, 2018

Flow splitting nCPAP device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,159,812
App. No.
13/074,990
Granted
Dec 25, 2018
Kind
B2
Abstract

A nCPAP device includes an net configured for receiving a single gas jet flow. The single gas jet flow supplies gas for both nares. The device also includes a flow splitter configured for proportionally splitting said gas jet flow into two channels for the both nares according to one or more of nave anatomy and flow path resistance.

Claims (37)

1. A nasal continuous positive airway pressure (nCPAP) device comprising:

a monolithic block comprising:

an inlet configured for receiving a single gas jet flow, wherein the single gas jet flow supplies gas for two nares of a patient;

a substantially triangular-shaped corner comprising a flow splitter configured for proportionally splitting the single gas jet flow into two channels for the nares according to a gas supply capacity of at least one nare of the patient, or flow path resistance of at least one nare of the patient; and

an exhaust port comprising a fixed aperture larger than an inlet aperture and the two channels for the nares, the exhaust port configured to conduct an expiratory airflow from the two channels for the nares to cause the single gas jet flow to deflect, and the exhaust port is further configured to alter an exhaust role and entrain an excess inhalation when a patient demand exceeds a flow rate supplied by the single gas jet flow wherein an axis perpendicular to the inlet is parallel to an axis perpendicular to the exhaust port.

2. The nasal continuous positive airway pressure (nCPAP) device of claim 1 , further comprising:

an interface configured for interfacing with nasal prongs.

3. The nasal continuous positive airway pressure (nCPAP) device of claim 1 , further comprising:

an interface configured for interfacing with a mask.

4. The nasal continuous positive airway pressure (nCPAP) device of claim 1 , wherein the flow splitter is further configured for facilitating a diversion of the single gas jet flow to the exhaust port.

5. The nasal continuous positive airway pressure (nCPAP) device of claim 1 , further comprising:

a pressure measurement port disposed in an exit channel.

6. The nasal continuous positive airway pressure (nCPAP) device of claim 1 , further comprising:

a nozzle for generating the single gas jet flow.

7. The nasal continuous positive airway pressure (nCPAP) device of claim 1 , wherein the flow splitter comprises:

a curving edge transition where at least one branched channel exhalation flow meets and diverts the single gas jet flow into the exhaust port.

8. The nasal continuous positive airway pressure (nCPAP) device of claim 1 , wherein the exhaust port is further configured to exhaust the single gas jet flow during exhalation.

9. The nasal continuous positive airway pressure (nCPAP) device of claim 1 , wherein the exhaust port is further configured to exhaust a portion of an expiratory airflow.

10. The nasal continuous positive airway pressure (nCPAP) device of claim 1 , further comprising a pressure measurement port on each of the two channels for the nares.

11. The nasal continuous positive airway pressure (nCPAP) device of claim 1 , further comprising a nozzle configured to provide the single gas jet flow.

12. The nasal continuous positive airway pressure (nCPAP) device of claim 1 , wherein the exhaust port is disposed in close proximity to an exit of a nozzle.

13. A method for splitting a gas jet flow in a nasal continuous positive airway pressure (nCPAP) system, the method comprising:

generating a single gas jet flow, wherein the single gas jet flow supplies gas for two nares of a patient;

providing the single gas jet flow to a monolithic block, the monolithic block comprising an inlet and an exhaust port, wherein an axis perpendicular to the inlet is parallel to an axis perpendicular to the exhaust port;

proportionally splitting, in the monolithic block, and by a substantially triangular-shaped corner comprising a flow splitter the single gas jet flow for the nares according to a gas supply capacity of at least one nare of the patient, or flow path resistance of a nare of the patient;

diverting, with least one branched channel exhalation flow, the single gas jet flow into the exhaust port along a curving edge transition in the flow splitter, wherein the exhaust port comprises a fixed aperture larger than an inlet aperture and larger than a channel for the nare of the patient, the fixed aperture disposed overlapping the flow splitter; and

altering an exhaust role of the exhaust port to entrain an excess inhalation flow in response to a patient demand exceeding a flow rate of the single gas jet flow.

14. The method of claim 13 , further comprising:

channeling the single gas jet flow after splitting to a device selected from a group consisting of: nasal prongs and a mask.

15. The method of claim 13 , wherein diverting the single gas jet flow through an exhaust port comprises deflecting the single gas jet flow with an exhalation flow.

16. The method of claim 13 , further comprising:

providing a patient exhalation flow and the single gas jet flow through the exhaust port during an exhalation phase.

17. The method of claim 13 , wherein the single gas jet flow supplies gas for two nares of an infant.

18. The method of claim 13 , further comprising:

measuring pressure via a pressure measurement port in each of two channels associated with each of the nares of the patient.

19. The method of claim 18 , further comprising:

monitoring the pressure of each of the two channels via a pressure monitoring port.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Dec 13, 2024
From: VYAIRE MEDICAL, INC., ET AL.'S CREDITORS
To: ZOLL MEDICAL CORPORATION
Reel/Frame 069635/0201 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2024
From: VYAIRE MEDICAL 211, INC.
To: ZOLL MEDICAL CORPORATION
Reel/Frame 069454/0907 →
MERGER Recorded Aug 26, 2022
From: VYAIRE MEDICAL 207, INC.
To: VYAIRE MEDICAL 211, INC.
Reel/Frame 061329/0785 →
CHANGE OF NAME Recorded May 4, 2022
From: CAREFUSION 207, INC.
To: VYAIRE MEDICAL 207, INC.
Reel/Frame 059852/0577 →
SECURITY INTEREST Recorded May 7, 2019
From: CAREFUSION 207, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 049109/0656 →
FIRST LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: CAREFUSION 207, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 045968/0497 →
SECOND LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: CAREFUSION 207, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 045969/0482 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2011
From: VARGA, CHRISTOPHER M.
To: CAREFUSION 207, INC.
Reel/Frame 026044/0803 →
Cited By (2)
US 12,364,831 US 12,383,689